VIVS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
VivoSim Labs Inc (VIVS) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, weak financial performance, and no positive catalysts. Additionally, there are no proprietary trading signals or significant trading trends to support a buy decision.
The technical indicators for VIVS are bearish. The MACD is negative and expanding downward, the RSI is neutral but leaning towards oversold, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.867 and resistance at 2.211. The stock also has a 100% chance of further declines in the short to medium term (-5.25% in the next day, -5.16% in the next week, -7.8% in the next month).
NULL. There are no recent news updates, no significant insider or hedge fund trading activity, and no recent congress trading data.
Additionally, the stock has a high probability of further declines in the short term.
In Q3 2026, VivoSim Labs Inc reported an 8.33% YoY increase in revenue to $26,000. However, net income dropped significantly to -$2,691,000 (-21.93% YoY), and EPS declined by 55.02% YoY to -1.03. Despite an increase in gross margin (up 9.09% YoY), the overall financial performance is weak, with substantial losses.
No data on analyst ratings or price target changes is provided.
